To hear about similar clinical trials, please enter your email below
Trial Title:
Staying Healthy With Follow-up Care: A Mobile Chatbot Feasibility Study for AYA Cancer Survivors
NCT ID:
NCT05863702
Condition:
Survivorship
Conditions: Keywords:
Survivorship
Pediatric Cancers
Young Adult Cancers
Study type:
Interventional
Study phase:
N/A
Overall status:
Recruiting
Study design:
Allocation:
Randomized
Intervention model:
Parallel Assignment
Primary purpose:
Supportive Care
Masking:
Single (Investigator)
Intervention:
Intervention type:
Behavioral
Intervention name:
Penny
Description:
The chatbot will assist patients who have not been see for cancer follow-up care, with
scheduling follow-up appointments, labs, scans, specialty appointments, and monitor
compliance with the appointments made.
Arm group label:
Penny text-messaging program
Summary:
The purpose of this project is to identify effective strategies to assist survivors of
childhood and young adult cancers (diagnosed between birth and age 39) who have not
returned for follow-up cancer care for 3 or more years, to reengage with the health care
system. The investigator will evaluate the effect of a novel, bidirectional
conversational agent ("Penny"), compared to usual care, to assist patients with
scheduling appointments, lab work as well as scans and specialty appointments as needed.
Detailed description:
To achieve this, the investigator will use a two-arm randomized controlled trial to
explore how multilevel factors impact the acceptability and effectiveness of this
strategy by collecting qualitative and quantitative data from patients. Penny is a
conversational agent ("chatbot") that engages patients in real time via text messaging,
allowing for bidirectional communication and motivational cues to promote adherence. The
chatbot will assist patients who have not been see for cancer follow-up care, with
scheduling follow-up appointments, labs, scans, specialty appointments, and monitor
compliance with the appointments made.
Criteria for eligibility:
Criteria:
Inclusion Criteria:
- Adult patient (age > 18 years), male or female, diagnosed with cancer as a child or
as a young adult, between birth and 39 years of age
- Patient possession of a mobile device that can receive SMS texts
- Ability to respond to questions and engage with "Penny" in English
- Ability to provide informed consent to participate in the study
- Approval of the patient's oncology care team for the patient to be involved in the
study
Exclusion Criteria:
- Anyone who does not meet the inclusion criteria
- Patients with a history of thyroid cancer or skin cancers
Gender:
All
Minimum age:
18 Years
Maximum age:
N/A
Healthy volunteers:
Accepts Healthy Volunteers
Locations:
Facility:
Name:
Abramson Cancer Center of the University of Pennsylvania
Address:
City:
Philadelphia
Zip:
19104
Country:
United States
Status:
Recruiting
Contact:
Last name:
Linda Jacobs, PhD
Phone:
855-216-0098
Email:
PennCancerTrials@emergingmed.com
Start date:
September 11, 2023
Completion date:
May 31, 2025
Lead sponsor:
Agency:
Abramson Cancer Center at Penn Medicine
Agency class:
Other
Source:
Abramson Cancer Center at Penn Medicine
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05863702
